市場調査レポート

商品コード

1463315

口蹄疫の世界市場規模、シェア、成長分析、技術別、動物タイプ別 - 産業予測、2024～2031年

Global FMD Disease Market Size, Share, Growth Analysis, By Technique(Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines, Oil-based Vaccines)), By Animal Type(Cattle, Sheep and goat) - Industry Forecast 2024-2031

出版日: 2024年04月06日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の口蹄疫の市場規模は、2022年に23億9,000万米ドルとなり、予測期間中（2024～2031年）のCAGRは8.1%で、2023年の25億8,000万米ドルから、2031年までには48億2,000万米ドルに成長する見通しです。

動物用ワクチン、特に口蹄疫（FMD）対策を目的としたワクチンの世界の普及は、畜産物の需要増と動物数の増加により著しい成長を遂げています。この急増は、環境の変化や急速な世界化といった要因の影響を受け、近年家畜や人獣共通感染症の流行が高まっていることに起因しています。これらの要因は、世界各国の政府が共同体や畜産種を含む様々な動物に対する安全な医療行為を優先しているため、動物用ワクチン市場の牽引役として大きな役割を果たしています。人畜共通感染症病原体に対処する法律は先進国でも発展途上国でも施行されており、その国の国内総生産（GDP）に発生が深刻な経済的影響を及ぼす可能性があることを認識しています。このようなリスクを軽減するための対策としては、感染動物の淘汰や、最新の株を使用したワクチンの備蓄を適切に維持することなどが挙げられます。牛乳、鶏卵、食肉、織物などの製品需要の増加に牽引され、畜産部門に見られるダイナミックな成長は、高度な機械や最新技術への多大な投資を引き寄せています。疾病の発生に伴う多額の経済的損失を考慮すると、ワクチン接種などのFMD予防対策は、政府や畜産業界の民間関係者にとって極めて重要な介入策であると考えられています。決定的な治療法がないことから、特に感染経路が多様であることを考慮すると、ワクチン接種の重要性が強調されます。畜産がGDPに大きく寄与している発展途上国では、動物の健康管理に大きな関心が寄せられています。こうした国の政府機関は、家畜の健康を守るため、新薬の開発やワクチン接種プログラムを優先しています。逆に、特に北米や欧州のような豊かな地域では、動物の移動に厳しい措置や制限を設けており、FMDの発生を効果的に最小限に抑えているため、FMDワクチンへの依存度が低くなっています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要な投資の分析
主要な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

口蹄疫の世界市場：技術別

市場概要
従来型ワクチン（水酸化アルミニウム/サポニンベースのワクチン）
石油系ワクチン
緊急用ワクチン

口蹄疫の世界市場：動物タイプ別

市場概要
牛
羊・ヤギ
豚
その他（カモシカ、シカ、バイソン、ラクダ科動物）

口蹄疫の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

MSD Animal Health
Zoetis
Boehringer Ingelheim
Bayer AG
Indian Immunologicals Ltd.
Biogenesis-Bago
Ceva SantA（C）Animale
China Animal Husbandry Co., Ltd.（CAH）
Guangdong Dahuanong Animal Health Products Co., Ltd.
Heska Corporation
Indian Immunologicals Limited
Lanzhou Veterinary Research Institute
Limor de Colombia S.A.
Merial（Sanofi）
Minnesota Veterinary Diagnostic Laboratory
PVT-Polish Veterinary Pharmaceuticals Ltd.
RAKARB Veterinary Biotech.
Vecol S.A.
VA（C）toquinol
Bioveta a.s.

Product Code: SQMIG35E2021

Global FMD disease market size was valued at USD 2.39 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 4.82 billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

The global adoption of veterinary vaccines, particularly those aimed at combating Foot-and-Mouth Disease (FMD), has experienced significant growth due to the increased demand for animal products and a larger population of animals. This surge can be attributed to the heightened prevalence of livestock and zoonotic diseases in recent years, influenced by factors such as environmental changes and rapid globalization. These factors have played a substantial role in driving the veterinary vaccine market, as governments worldwide prioritize safe medical practices for various animals, including communal and livestock species. Legislation addressing zoonotic pathogens is in effect in both developed and developing nations, recognizing the potential severe economic consequences of an outbreak on a nation's gross domestic product (GDP). Measures to mitigate these risks include culling infected animals and maintaining adequate vaccine stockpiles with updated strains. The dynamic growth observed in the animal sector, driven by increasing demand for products such as milk, chicken eggs, meat, and fabric, has attracted significant investment in advanced machinery and modern technologies. Preventive measures against FMD, such as vaccination, are deemed crucial interventions by governments and private stakeholders in the animal industry, given the substantial financial losses associated with disease outbreaks. The absence of a definitive cure underscores the importance of vaccination, particularly considering the various means through which infection can occur. In developing countries where livestock production significantly contributes to GDP, animal healthcare practices receive considerable attention. Government organizations in these nations prioritize the development of new medications and vaccination programs to safeguard cattle health. Conversely, regions with stringent measures and restrictions on animal movement, particularly in affluent areas like North America and Europe, have effectively minimized FMD outbreaks and thus have reduced reliance on FMD vaccines.

Top-down and bottom-up approaches were used to estimate and validate the size of the global FMD disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global FMD Disease Market Segmental Analysis

The global FMD disease market is segmented based on technique, animal type, and region. By technique, the market is segmented into conventional vaccines (aluminum hydroxide/saponin-based vaccines, oil-based vaccines), and emergency vaccines. By animal type, the market is segmented into cattle, sheep and goat, pigs, others (antelope, deer, bison, and camelids). By region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global FMD Disease Market

The increasing demand for animal protein and dairy products serves as a significant catalyst for the Foot-and-Mouth Disease (FMD) market, given the potential for substantial losses within the livestock industry caused by FMD outbreaks.

Restraints in the Global FMD Disease Market

The substantial expenses associated with FMD vaccines and diagnostic tests represent a significant barrier to the FMD market, especially in developing nations with extensive livestock populations.

Market Trends of the Global FMD Disease Market

A prominent market trend is the rising demand for Foot-and-Mouth Disease (FMD) vaccines, especially evident in developing nations. Governments worldwide are implementing initiatives to mitigate and prevent FMD outbreaks, thereby fueling the demand for FMD vaccines.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global FMD Disease Market by Technique

Market Overview
Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines
Oil-based Vaccines)
and Emergency Vaccines

Global FMD Disease Market by Animal Type

Market Overview
Cattle
Sheep and goat
Pigs
and Others (antelope
deer
bison
and camelids)

Global FMD Disease Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

MSD Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis-Bago
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva SantA(C) Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Animal Husbandry Co., Ltd. (CAH)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guangdong Dahuanong Animal Health Products Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lanzhou Veterinary Research Institute
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Limor de Colombia S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merial (Sanofi)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minnesota Veterinary Diagnostic Laboratory
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PVT-Polish Veterinary Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RAKARB Veterinary Biotech.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vecol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VA(C)toquinol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioveta a.s.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments